Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum

Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum

To clarify the clinical outcome of peripheral T-cell lymphomas (PTCLs), we conducted a retrospective review comparing the outcomes of patients with PTCL (nodal peripheral T-cell lymphoma, unspecified, n=34 ; angioimmunoblastic T-cell lymphoma, n=12) to those with diffuse large B-cell lymphoma (DLBCL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Clinical and Experimental Hematopathology 2011, Vol.51(1), pp.29-35
Hauptverfasser: Akagi, Tomoaki, Takahashi, Naoto, Yamaguchi, Kouhei, Ishizawa, Kenichi, Murai, Kazunori, Tajima, Katsushi, Ikeda, Kazuhiko, Kameoka, Yoshihiro, Kameoka, Junnichi, Ito, Shigeki, Kato, Yuichi, Noji, Hideyoshi, Shichishima, Tsutomu, Itoh, Jugoh, Ichinohasama, Ryo, Harigae, Hideo, Ishida, Yoji, Sawada, Kenichi
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Asian Continental Ancestry Group
CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone)
Cyclophosphamide - therapeutic use
diffuse large B-cell lymphoma
Doxorubicin - therapeutic use
Female
Humans
Immunophenotyping
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - mortality
Lymphoma, T-Cell, Peripheral - drug therapy
Lymphoma, T-Cell, Peripheral - mortality
Male
Middle Aged
peripheral T-cell lymphomas
Prednisone - therapeutic use
Prognosis
Retrospective Studies
survival
Treatment Outcome
Vincristine - therapeutic use
Young Adult
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To clarify the clinical outcome of peripheral T-cell lymphomas (PTCLs), we conducted a retrospective review comparing the outcomes of patients with PTCL (nodal peripheral T-cell lymphoma, unspecified, n=34 ; angioimmunoblastic T-cell lymphoma, n=12) to those with diffuse large B-cell lymphoma (DLBCL, n=48). All patients received CHOP-based chemotherapy without rituximab. PTCL patients presented at a more advanced clinical stage (91% vs. 65%, P
ISSN:1346-4280
1880-9952
DOI:10.3960/jslrt.51.29